---
title: High Ano1 expression as key driver of resistance to radiation and cisplatin
  in HPV-negative head and neck squamous cell carcinoma
date: '2025-01-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39789065/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250110170846&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Human papilloma virus-negative head and neck squamous cell carcinoma
  (HNSCC) frequently harbors 11q13 amplifications. Among the oncogenes at this locus,
  CCND1 and ANO1 are linked to poor prognosis; however, their individual roles in
  treatment resistance remain unclear. The impact of Cyclin D1 and Ano1 overexpression
  on survival was analyzed using the TCGA HNSCC dataset and a Charité cohort treated
  with cisplatin (CDDP)-based radiochemotherapy. High Ano1 expression was primarily
  associated ...
disable_comments: true
---
Human papilloma virus-negative head and neck squamous cell carcinoma (HNSCC) frequently harbors 11q13 amplifications. Among the oncogenes at this locus, CCND1 and ANO1 are linked to poor prognosis; however, their individual roles in treatment resistance remain unclear. The impact of Cyclin D1 and Ano1 overexpression on survival was analyzed using the TCGA HNSCC dataset and a Charité cohort treated with cisplatin (CDDP)-based radiochemotherapy. High Ano1 expression was primarily associated ...